Combination treatment for nonhematologic malignancies using an anti-igf-1r antibody
Details for Australian Patent Application No. 2005264063 (hide)
International Classifications
Event Publications
25 January 2007 PCT application entered the National Phase
PCT publication WO2006/008639 Priority application(s): WO2006/008639
10 September 2009 Application Accepted
Published as AU-B-2005264063
24 December 2009 Opposition Lodged
Amgen Inc. has lodged an opposition against Pfizer Products Inc.
25 March 2010 Opposition Withdrawn
The opposition by Amgen Inc. against Pfizer Products Inc has been withdrawn.
23 February 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005264065-Hair growth promoting agents
2005264062-System and method for increasing data throughput using a block acknowledgement
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser